5-HTP

5-HTP sits at a strange crossroads in the supplement world: it has more pharmacologically credible evidence than most adaptogens but is sold next to them as if it were equally benign. It isn’t. 5-HTP works by raising serotonin — the same mechanism as SSRI antidepressants — which means it can produce real benefits in the right person and serious problems in the wrong context.

The mechanism is straightforward. Dietary tryptophan converts to 5-HTP via tryptophan hydroxylase (a rate-limited enzyme), and 5-HTP then converts to serotonin via decarboxylation. Taking 5-HTP directly bypasses the rate-limiting step, which is why a 100 mg oral dose can produce measurable brain serotonin changes that 1 g of tryptophan often can’t.

The clinical evidence is real but small. Two trials met Cochrane’s quality threshold and both showed 5-HTP superior to placebo for depression. Sleep trials are smaller still but consistent: shortened sleep onset, increased REM sleep, modest improvements in subjective sleep quality. Appetite trials in overweight women show reduced food intake and early satiety — the mechanism is the same one that makes SSRIs cause appetite changes. None of these effect sizes match modern antidepressants for severe depression. None of them are large enough to recommend 5-HTP as first-line for any condition. But for someone with mild symptoms looking for a less-intensive intervention, the evidence is there.

The risks are also real and underemphasized in marketing. Serotonin syndrome — a potentially fatal hyperserotonergic state — can occur when 5-HTP is combined with any other serotonergic agent. This includes SSRIs (sertraline, fluoxetine, escitalopram, paroxetine), SNRIs (venlafaxine, duloxetine), MAOIs, tramadol, dextromethorphan (the cough suppressant in DayQuil and many cold medicines), St. John’s Wort, lithium, and migraine triptans. The threshold for syndrome onset varies but case reports exist at moderate doses. This is not a theoretical risk — it’s a documented one with deaths in the literature.

The 1989 EMS outbreak deserves honest treatment. Eosinophilia-myalgia syndrome was caused by a contaminant in L-tryptophan from a single Japanese manufacturer (Showa Denko) — not by tryptophan itself. The FDA banned tryptophan for a decade. Modern 5-HTP from Griffonia seeds uses a different extraction process and has not been associated with EMS, but quality sourcing matters: third-party tested products from reputable brands (Now Foods, Doctor’s Best, Pure Encapsulations) are preferred over no-name imports.

Practical guidance: start at 50 mg once daily, taken on an empty stomach. Nausea is dose-dependent and the most common side effect. If tolerated, ramp to 100 mg over a week. For sleep, 100-200 mg 30-60 minutes before bed. For mood support, 50-100 mg twice daily (morning and afternoon). Don’t take with protein meals (competes with absorption). Cycle 5 days on, 2 off if used chronically. If you’re on any antidepressant, anti-anxiety medication, migraine medication, or even cold medicines containing dextromethorphan, do not take 5-HTP without explicit clearance from your doctor.

5-HTP is one of the few supplements where the question “could this hurt me?” has a real answer beyond “probably not.” Treat it accordingly.